Specialist in | HCG Oncology

Didn't find what you were looking for?

Feel free to reach out to us.

Introduction

Dr. Amit is a highly experienced pediatric haemato oncologist with 5 years of experience in managing various solid tumours and haematological malignancies. He has a special interest in the management of thalassemia, ITP, sickle cell anaemia, haemophilia, AIHA and paediatric anaemia, and is experienced in administering autologous and allogeneic blood and bone marrow transplants. Dr. Amit takes a holistic approach to treating his patients, focusing on providing compassionate care while delivering comprehensive and evidence-based medical treatments.

Area of Expertise

Dr. Amit is a skilled pediatric haemato oncologist with around 5 years of experience.
His expertise lies in the management of various solid tumours and haematological malignancies, namely leukaemias, lymphomas, paediatric ALL, AML, osteosarcoma, Ewing sarcoma, neuroblastoma, Wilms tumour, retinoblastoma, RMS, STS, etc.
Dr. Amit has also has an interest in the management of thalassaemia, ITP, sickle cell anaemia, haemophilia, AIHA, paediatric anaemia, etc.
He is also experienced in administering autologous and allogeneic blood and bone marrow transplants for paediatric malignancies and benign haematological disorders, such as thalassaemia and sickle cell anaemia.

Medical Breakthrough

He has multiple publications indexed in various reputed journals.
Dr. Amit has presented posters and papers at multiple national and international conferences.
He has delivered lectures at various CMEs.
Dr. Amit is a lifetime member of the central IAP and Indian Paediatric Haematology and Oncology Group. He is also a member of IAP BPS, Bengaluru.
A bright student during his academic days, Dr. Amit has won a state level IAP quiz during his MD programme.
He is also a recipient of numerous poster awards.

Awards & Accolades

Dr. Amit has completed his fellowship training in paediatric haemato oncology and paediatric BMT.
He has also received his fellowship training in paediatric intensive infection prevention course in immunocompromised paediatric patients.